Global Peripheral Vascular Intervention Products Market Research Report 2026

Peripheral Vascular Intervention Products Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Peripheral Vascular Intervention Products competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Peripheral Vascular intervention refers to medical procedures performed to diagnose and treat conditions affecting the blood vessels outside the heart and brain, primarily the arteries and veins in the arms, legs, abdomen, and pelvis. These interventions are typically minimally invasive and are aimed at restoring or improving blood flow to the affected peripheral tissues. Peripheral intervention procedures include angioplasty, stenting, atherectomy, thrombectomy, embolization, and other techniques used to address various conditions such as peripheral artery disease (PAD), deep vein thrombosis (DVT), venous insufficiency, aneurysms, and vascular malformations. These procedures are often performed by interventional radiologists, vascular surgeons, or cardiologists using catheter-based techniques guided by imaging modalities such as fluoroscopy, ultrasound, or computed tomography (CT). Peripheral intervention plays a crucial role in improving patient outcomes, relieving symptoms, preventing complications, and preserving limb function in individuals with peripheral vascular diseases.In 2025, global Peripheral Vascular Intervention Products production reached approximately 93.66 million units and price is about 120.6 USD/Unit.The average gross profit margin of this product is 73%.

Rising burdens of aging, diabetes, and atherosclerotic disease sustain long-term demand for PAD and venous thrombotic care. The clinical advantages of endovascular therapy—less invasiveness, faster recovery, and repeatability—continue to shift more patients from surgical to endoluminal strategies. Hospitals are also prioritizing peri-procedural efficiency and longitudinal disease management, making integrated solutions that combine devices with imaging assessment and follow-up pathways more likely to be adopted and standardized.Peripheral anatomy and lesion morphology vary widely, with a high proportion of long lesions and calcification, leading to strong outcome stratification across device strategies and persistent restenosis risk—requiring ongoing evidence building and clear indication boundaries. Complication control (perforation, dissection, distal embolization, stent fracture, etc.) raises requirements for operator expertise and device reliability. Meanwhile, cost-containment and tender dynamics intensify price pressure, forcing suppliers to prove value through real-world outcomes, comprehensive portfolios, and robust clinical education—without which sustainable access and brand stickiness are difficult.Downstream purchasing is shifting from single-device selection toward lesion-centered combination strategies, favoring product matrices that cover complex scenarios such as long lesions, bifurcations, calcification, and thrombosis, and that integrate well with intravascular imaging, functional assessment, and precise sizing. Drug-coated and vessel-remodeling approaches are increasingly evaluated on safety, durable patency, and reintervention management, while demand rises for simplified workflows, complication alerts, and post-procedure management tools. The growth of outpatient and day-case procedures further pushes devices toward easier use, standardization, and reproducible clinical pathways.Upstream value is anchored in high-performance metals and polymer systems. Stent frameworks commonly rely on nitinol and stainless steel; guidewires and braided structures require high-strength metallic wire. Balloons and catheters often use nylon and Pebax with braided/coil reinforcement. Hydrophilic coatings, lubricious layers, adhesives, radiopaque markers, and sterile packaging shape deliverability, visibility, and safety margins. Drug-coated devices additionally depend on consistent control of drug–excipient stability and coating uniformity. Key competitive factors include batch consistency of raw materials, precision processing and clean manufacturing, stable coating/sterilization processes, and resilient supply of critical components.

This report delivers a comprehensive overview of the global Peripheral Vascular Intervention Products market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Peripheral Vascular Intervention Products. The Peripheral Vascular Intervention Products market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Peripheral Vascular Intervention Products market comprehensively. Regional market sizes by Type, by Application, by Vascular Bed, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Peripheral Vascular Intervention Products manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Peripheral Vascular Intervention Products Market Report

Chapter Outline

1.1 Product Definition

1.2 Peripheral Vascular Intervention Products by Type

1.2.1 Global Peripheral Vascular Intervention Products Market Value by Type: 2025 vs 2032

1.2.2 Stent

1.2.3 Catheter

1.2.4 Guidewire

1.2.5 Sheath

1.2.6 Vena Cava Filter

1.2.7 Other

1.3 Peripheral Vascular Intervention Products by Vascular Bed

1.3.1 Global Peripheral Vascular Intervention Products Market Value by Vascular Bed: 2025 vs 2032

1.3.2 Lower Limb Artery

1.3.3 Carotid/Neck

1.3.4 Vein

1.3.5 Renal/Visceral Artery

1.3.6 Other

1.4 Peripheral Vascular Intervention Products by Drug Strategy

1.4.1 Global Peripheral Vascular Intervention Products Market Value by Drug Strategy: 2025 vs 2032

1.4.2 Non-drug

1.4.3 Drug-coated

1.4.4 Drug-eluting

1.4.5 Other

1.5 Peripheral Vascular Intervention Products by Application

1.5.1 Global Peripheral Vascular Intervention Products Market Value by Application: 2025 vs 2032

1.5.2 Arterial Diseases

1.5.3 Venous Diseases

1.6 Global Peripheral Vascular Intervention Products Market Size Estimates and Forecasts

1.6.1 Global Peripheral Vascular Intervention Products Revenue 2021–2032

1.6.2 Global Peripheral Vascular Intervention Products Sales 2021–2032

1.6.3 Global Peripheral Vascular Intervention Products Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2.1 Global Peripheral Vascular Intervention Products Sales Market Share by Manufacturers (2021–2026)

2.2 Global Peripheral Vascular Intervention Products Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Peripheral Vascular Intervention Products Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Peripheral Vascular Intervention Products, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Peripheral Vascular Intervention Products, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Peripheral Vascular Intervention Products, Product Types and Applications

2.7 Global Key Manufacturers of Peripheral Vascular Intervention Products, Date of Entry into the Industry

2.8 Global Peripheral Vascular Intervention Products Market Competitive Situation and Trends

2.8.1 Global Peripheral Vascular Intervention Products Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Peripheral Vascular Intervention Products Players Market Share by Revenue

2.8.3 Global Peripheral Vascular Intervention Products Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Peripheral Vascular Intervention Products Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Peripheral Vascular Intervention Products Sales by Region: 2021–2032

3.2.1 Global Peripheral Vascular Intervention Products Sales by Region: 2021–2026

3.2.2 Global Peripheral Vascular Intervention Products Sales by Region: 2027–2032

3.3 Global Peripheral Vascular Intervention Products Revenue by Region: 2021–2032

3.3.1 Global Peripheral Vascular Intervention Products Revenue by Region: 2021–2026

3.3.2 Global Peripheral Vascular Intervention Products Revenue by Region: 2027–2032

3.4 North America Peripheral Vascular Intervention Products Market Facts & Figures by Country

3.4.1 North America Peripheral Vascular Intervention Products Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Peripheral Vascular Intervention Products Sales by Country (2021–2032)

3.4.3 North America Peripheral Vascular Intervention Products Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Peripheral Vascular Intervention Products Market Facts & Figures by Country

3.5.1 Europe Peripheral Vascular Intervention Products Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Peripheral Vascular Intervention Products Sales by Country (2021–2032)

3.5.3 Europe Peripheral Vascular Intervention Products Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Peripheral Vascular Intervention Products Market Facts & Figures by Region

3.6.1 Asia Pacific Peripheral Vascular Intervention Products Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Peripheral Vascular Intervention Products Sales by Region (2021–2032)

3.6.3 Asia Pacific Peripheral Vascular Intervention Products Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Peripheral Vascular Intervention Products Market Facts & Figures by Country

3.7.1 Latin America Peripheral Vascular Intervention Products Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Peripheral Vascular Intervention Products Sales by Country (2021–2032)

3.7.3 Latin America Peripheral Vascular Intervention Products Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Peripheral Vascular Intervention Products Market Facts & Figures by Country

3.8.1 Middle East and Africa Peripheral Vascular Intervention Products Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Peripheral Vascular Intervention Products Sales by Country (2021–2032)

3.8.3 Middle East and Africa Peripheral Vascular Intervention Products Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Peripheral Vascular Intervention Products Sales by Type (2021–2032)

4.1.1 Global Peripheral Vascular Intervention Products Sales by Type (2021–2026)

4.1.2 Global Peripheral Vascular Intervention Products Sales by Type (2027–2032)

4.1.3 Global Peripheral Vascular Intervention Products Sales Market Share by Type (2021–2032)

4.2 Global Peripheral Vascular Intervention Products Revenue by Type (2021–2032)

4.2.1 Global Peripheral Vascular Intervention Products Revenue by Type (2021–2026)

4.2.2 Global Peripheral Vascular Intervention Products Revenue by Type (2027–2032)

4.2.3 Global Peripheral Vascular Intervention Products Revenue Market Share by Type (2021–2032)

4.3 Global Peripheral Vascular Intervention Products Price by Type (2021–2032)

5.1 Global Peripheral Vascular Intervention Products Sales by Application (2021–2032)

5.1.1 Global Peripheral Vascular Intervention Products Sales by Application (2021–2026)

5.1.2 Global Peripheral Vascular Intervention Products Sales by Application (2027–2032)

5.1.3 Global Peripheral Vascular Intervention Products Sales Market Share by Application (2021–2032)

5.2 Global Peripheral Vascular Intervention Products Revenue by Application (2021–2032)

5.2.1 Global Peripheral Vascular Intervention Products Revenue by Application (2021–2026)

5.2.2 Global Peripheral Vascular Intervention Products Revenue by Application (2027–2032)

5.2.3 Global Peripheral Vascular Intervention Products Revenue Market Share by Application (2021–2032)

5.3 Global Peripheral Vascular Intervention Products Price by Application (2021–2032)

6.1 Abbott

6.1.1 Abbott Company Information

6.1.2 Abbott Description and Business Overview

6.1.3 Abbott Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Abbott Peripheral Vascular Intervention Products Product Portfolio

6.1.5 Abbott Recent Developments/Updates

6.2 BD

6.2.1 BD Company Information

6.2.2 BD Description and Business Overview

6.2.3 BD Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 BD Peripheral Vascular Intervention Products Product Portfolio

6.2.5 BD Recent Developments/Updates

6.3 Biotronik

6.3.1 Biotronik Company Information

6.3.2 Biotronik Description and Business Overview

6.3.3 Biotronik Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Biotronik Peripheral Vascular Intervention Products Product Portfolio

6.3.5 Biotronik Recent Developments/Updates

6.4 Boston Scientific

6.4.1 Boston Scientific Company Information

6.4.2 Boston Scientific Description and Business Overview

6.4.3 Boston Scientific Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Boston Scientific Peripheral Vascular Intervention Products Product Portfolio

6.4.5 Boston Scientific Recent Developments/Updates

6.5 Medtronic

6.5.1 Medtronic Company Information

6.5.2 Medtronic Description and Business Overview

6.5.3 Medtronic Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Medtronic Peripheral Vascular Intervention Products Product Portfolio

6.5.5 Medtronic Recent Developments/Updates

6.6 Merit Medical

6.6.1 Merit Medical Company Information

6.6.2 Merit Medical Description and Business Overview

6.6.3 Merit Medical Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Merit Medical Peripheral Vascular Intervention Products Product Portfolio

6.6.5 Merit Medical Recent Developments/Updates

6.7 Terumo

6.7.1 Terumo Company Information

6.7.2 Terumo Description and Business Overview

6.7.3 Terumo Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Terumo Peripheral Vascular Intervention Products Product Portfolio

6.7.5 Terumo Recent Developments/Updates

6.8 Teleflex

6.8.1 Teleflex Company Information

6.8.2 Teleflex Description and Business Overview

6.8.3 Teleflex Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Teleflex Peripheral Vascular Intervention Products Product Portfolio

6.8.5 Teleflex Recent Developments/Updates

6.9 Cook Medical

6.9.1 Cook Medical Company Information

6.9.2 Cook Medical Description and Business Overview

6.9.3 Cook Medical Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Cook Medical Peripheral Vascular Intervention Products Product Portfolio

6.9.5 Cook Medical Recent Developments/Updates

6.10 Cordis

6.10.1 Cordis Company Information

6.10.2 Cordis Description and Business Overview

6.10.3 Cordis Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Cordis Peripheral Vascular Intervention Products Product Portfolio

6.10.5 Cordis Recent Developments/Updates

6.11 Alvimedica

6.11.1 Alvimedica Company Information

6.11.2 Alvimedica Description and Business Overview

6.11.3 Alvimedica Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Alvimedica Peripheral Vascular Intervention Products Product Portfolio

6.11.5 Alvimedica Recent Developments/Updates

6.12 Lepu Medical

6.12.1 Lepu Medical Company Information

6.12.2 Lepu Medical Description and Business Overview

6.12.3 Lepu Medical Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Lepu Medical Peripheral Vascular Intervention Products Product Portfolio

6.12.5 Lepu Medical Recent Developments/Updates

6.13 Guichuangtongqiao

6.13.1 Guichuangtongqiao Company Information

6.13.2 Guichuangtongqiao Description and Business Overview

6.13.3 Guichuangtongqiao Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Guichuangtongqiao Peripheral Vascular Intervention Products Product Portfolio

6.13.5 Guichuangtongqiao Recent Developments/Updates

6.14 Xinmai Medical

6.14.1 Xinmai Medical Company Information

6.14.2 Xinmai Medical Description and Business Overview

6.14.3 Xinmai Medical Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Xinmai Medical Peripheral Vascular Intervention Products Product Portfolio

6.14.5 Xinmai Medical Recent Developments/Updates

6.15 Xenrad Medical

6.15.1 Xenrad Medical Company Information

6.15.2 Xenrad Medical Description and Business Overview

6.15.3 Xenrad Medical Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 Xenrad Medical Peripheral Vascular Intervention Products Product Portfolio

6.15.5 Xenrad Medical Recent Developments/Updates

6.16 Xianjian Technology

6.16.1 Xianjian Technology Company Information

6.16.2 Xianjian Technology Description and Business Overview

6.16.3 Xianjian Technology Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.16.4 Xianjian Technology Peripheral Vascular Intervention Products Product Portfolio

6.16.5 Xianjian Technology Recent Developments/Updates

6.17 Weigao Shares

6.17.1 Weigao Shares Company Information

6.17.2 Weigao Shares Description and Business Overview

6.17.3 Weigao Shares Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.17.4 Weigao Shares Peripheral Vascular Intervention Products Product Portfolio

6.17.5 Weigao Shares Recent Developments/Updates

6.18 Bomei Medical

6.18.1 Bomei Medical Company Information

6.18.2 Bomei Medical Description and Business Overview

6.18.3 Bomei Medical Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.18.4 Bomei Medical Peripheral Vascular Intervention Products Product Portfolio

6.18.5 Bomei Medical Recent Developments/Updates

6.19 Dingke Medical

6.19.1 Dingke Medical Company Information

6.19.2 Dingke Medical Description and Business Overview

6.19.3 Dingke Medical Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.19.4 Dingke Medical Peripheral Vascular Intervention Products Product Portfolio

6.19.5 Dingke Medical Recent Developments/Updates

6.20 Zhejiang Batai Medical

6.20.1 Zhejiang Batai Medical Company Information

6.20.2 Zhejiang Batai Medical Description and Business Overview

6.20.3 Zhejiang Batai Medical Peripheral Vascular Intervention Products Sales, Revenue, and Gross Margin (2021–2026)

6.20.4 Zhejiang Batai Medical Peripheral Vascular Intervention Products Product Portfolio

6.20.5 Zhejiang Batai Medical Recent Developments/Updates

7.1 Peripheral Vascular Intervention Products Industry Chain Analysis

7.2 Peripheral Vascular Intervention Products Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Peripheral Vascular Intervention Products Production Mode & Process Analysis

7.4 Peripheral Vascular Intervention Products Sales and Marketing

7.4.1 Peripheral Vascular Intervention Products Sales Channels

7.4.2 Peripheral Vascular Intervention Products Distributors

7.5 Peripheral Vascular Intervention Products Customer Analysis

8.1 Peripheral Vascular Intervention Products Industry Trends

8.2 Peripheral Vascular Intervention Products Market Drivers

8.3 Peripheral Vascular Intervention Products Market Challenges

8.4 Peripheral Vascular Intervention Products Market Restraints

8.5 Impact of U.S. Tariffs

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

 Table 1. Global Peripheral Vascular Intervention Products Market Value by Type (US$ Million), 2025 vs 2032

 Table 2. Global Peripheral Vascular Intervention Products Market Value by Vascular Bed (US$ Million), 2025 vs 2032

 Table 3. Global Peripheral Vascular Intervention Products Market Value by Drug Strategy (US$ Million), 2025 vs 2032

 Table 4. Global Peripheral Vascular Intervention Products Market Value by Application (US$ Million), 2025 vs 2032

 Table 5. Global Peripheral Vascular Intervention Products Market Competitive Situation by Manufacturers in 2025

 Table 6. Global Peripheral Vascular Intervention Products Sales (K Units) of Key Manufacturers (2021–2026)

 Table 7. Global Peripheral Vascular Intervention Products Sales Market Share by Manufacturers (2021–2026)

 Table 8. Global Peripheral Vascular Intervention Products Revenue (US$ Million) by Manufacturers (2021–2026)

 Table 9. Global Peripheral Vascular Intervention Products Revenue Share by Manufacturers (2021–2026)

 Table 10. Global Market Peripheral Vascular Intervention Products Average Price (US$/Unit) of Key Manufacturers (2021–2026)

 Table 11. Global Key Players of Peripheral Vascular Intervention Products, Industry Ranking, 2023 vs 2024 vs 2025

 Table 12. Global Key Manufacturers of Peripheral Vascular Intervention Products, Manufacturing Sites and Headquarters

 Table 13. Global Key Manufacturers of Peripheral Vascular Intervention Products, Product Types and Applications

 Table 14. Global Key Manufacturers of Peripheral Vascular Intervention Products, Date of Entry into the Industry

 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

 Table 16. Global Peripheral Vascular Intervention Products Companies by Tier (Tier 1, Tier 2, Tier 3), based on Peripheral Vascular Intervention Products Revenue, 2025

 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

 Table 18. Global Peripheral Vascular Intervention Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 19. Global Peripheral Vascular Intervention Products Sales by Region (K Units), 2021–2026

 Table 20. Global Peripheral Vascular Intervention Products Sales Market Share by Region (2021–2026)

 Table 21. Global Peripheral Vascular Intervention Products Sales by Region (K Units), 2027–2032

 Table 22. Global Peripheral Vascular Intervention Products Sales Market Share by Region (2027–2032)

 Table 23. Global Peripheral Vascular Intervention Products Revenue by Region (US$ Million), 2021–2026

 Table 24. Global Peripheral Vascular Intervention Products Revenue Market Share by Region (2021–2026)

 Table 25. Global Peripheral Vascular Intervention Products Revenue by Region (US$ Million), 2027–2032

 Table 26. Global Peripheral Vascular Intervention Products Revenue Market Share by Region (2027–2032)

 Table 27. North America Peripheral Vascular Intervention Products Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 28. North America Peripheral Vascular Intervention Products Sales by Country (K Units), 2021–2026

 Table 29. North America Peripheral Vascular Intervention Products Sales by Country (K Units), 2027–2032

 Table 30. North America Peripheral Vascular Intervention Products Revenue by Country (US$ Million), 2021–2026

 Table 31. North America Peripheral Vascular Intervention Products Revenue by Country (US$ Million), 2027–2032

 Table 32. Europe Peripheral Vascular Intervention Products Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 33. Europe Peripheral Vascular Intervention Products Sales by Country (K Units), 2021–2026

 Table 34. Europe Peripheral Vascular Intervention Products Sales by Country (K Units), 2027–2032

 Table 35. Europe Peripheral Vascular Intervention Products Revenue by Country (US$ Million), 2021–2026

 Table 36. Europe Peripheral Vascular Intervention Products Revenue by Country (US$ Million), 2027–2032

 Table 37. Asia Pacific Peripheral Vascular Intervention Products Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

 Table 38. Asia Pacific Peripheral Vascular Intervention Products Sales by Region (K Units), 2021–2026

 Table 39. Asia Pacific Peripheral Vascular Intervention Products Sales by Region (K Units), 2027–2032

 Table 40. Asia Pacific Peripheral Vascular Intervention Products Revenue by Region (US$ Million), 2021–2026

 Table 41. Asia Pacific Peripheral Vascular Intervention Products Revenue by Region (US$ Million), 2027–2032

 Table 42. Latin America Peripheral Vascular Intervention Products Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 43. Latin America Peripheral Vascular Intervention Products Sales by Country (K Units), 2021–2026

 Table 44. Latin America Peripheral Vascular Intervention Products Sales by Country (K Units), 2027–2032

 Table 45. Latin America Peripheral Vascular Intervention Products Revenue by Country (US$ Million), 2021–2026

 Table 46. Latin America Peripheral Vascular Intervention Products Revenue by Country (US$ Million), 2027–2032

 Table 47. Middle East and Africa Peripheral Vascular Intervention Products Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 48. Middle East and Africa Peripheral Vascular Intervention Products Sales by Country (K Units), 2021–2026

 Table 49. Middle East and Africa Peripheral Vascular Intervention Products Sales by Country (K Units), 2027–2032

 Table 50. Middle East and Africa Peripheral Vascular Intervention Products Revenue by Country (US$ Million), 2021–2026

 Table 51. Middle East and Africa Peripheral Vascular Intervention Products Revenue by Country (US$ Million), 2027–2032

 Table 52. Global Peripheral Vascular Intervention Products Sales (K Units) by Type (2021–2026)

 Table 53. Global Peripheral Vascular Intervention Products Sales (K Units) by Type (2027–2032)

 Table 54. Global Peripheral Vascular Intervention Products Sales Market Share by Type (2021–2026)

 Table 55. Global Peripheral Vascular Intervention Products Sales Market Share by Type (2027–2032)

 Table 56. Global Peripheral Vascular Intervention Products Revenue (US$ Million) by Type (2021–2026)

 Table 57. Global Peripheral Vascular Intervention Products Revenue (US$ Million) by Type (2027–2032)

 Table 58. Global Peripheral Vascular Intervention Products Revenue Market Share by Type (2021–2026)

 Table 59. Global Peripheral Vascular Intervention Products Revenue Market Share by Type (2027–2032)

 Table 60. Global Peripheral Vascular Intervention Products Price (US$/Unit) by Type (2021–2026)

 Table 61. Global Peripheral Vascular Intervention Products Price (US$/Unit) by Type (2027–2032)

 Table 62. Global Peripheral Vascular Intervention Products Sales (K Units) by Application (2021–2026)

 Table 63. Global Peripheral Vascular Intervention Products Sales (K Units) by Application (2027–2032)

 Table 64. Global Peripheral Vascular Intervention Products Sales Market Share by Application (2021–2026)

 Table 65. Global Peripheral Vascular Intervention Products Sales Market Share by Application (2027–2032)

 Table 66. Global Peripheral Vascular Intervention Products Revenue (US$ Million) by Application (2021–2026)

 Table 67. Global Peripheral Vascular Intervention Products Revenue (US$ Million) by Application (2027–2032)

 Table 68. Global Peripheral Vascular Intervention Products Revenue Market Share by Application (2021–2026)

 Table 69. Global Peripheral Vascular Intervention Products Revenue Market Share by Application (2027–2032)

 Table 70. Global Peripheral Vascular Intervention Products Price (US$/Unit) by Application (2021–2026)

 Table 71. Global Peripheral Vascular Intervention Products Price (US$/Unit) by Application (2027–2032)

 Table 72. Abbott Company Information

 Table 73. Abbott Description and Business Overview

 Table 74. Abbott Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 75. Abbott Peripheral Vascular Intervention Products Product

 Table 76. Abbott Recent Developments/Updates

 Table 77. BD Company Information

 Table 78. BD Description and Business Overview

 Table 79. BD Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 80. BD Peripheral Vascular Intervention Products Product

 Table 81. BD Recent Developments/Updates

 Table 82. Biotronik Company Information

 Table 83. Biotronik Description and Business Overview

 Table 84. Biotronik Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 85. Biotronik Peripheral Vascular Intervention Products Product

 Table 86. Biotronik Recent Developments/Updates

 Table 87. Boston Scientific Company Information

 Table 88. Boston Scientific Description and Business Overview

 Table 89. Boston Scientific Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 90. Boston Scientific Peripheral Vascular Intervention Products Product

 Table 91. Boston Scientific Recent Developments/Updates

 Table 92. Medtronic Company Information

 Table 93. Medtronic Description and Business Overview

 Table 94. Medtronic Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 95. Medtronic Peripheral Vascular Intervention Products Product

 Table 96. Medtronic Recent Developments/Updates

 Table 97. Merit Medical Company Information

 Table 98. Merit Medical Description and Business Overview

 Table 99. Merit Medical Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 100. Merit Medical Peripheral Vascular Intervention Products Product

 Table 101. Merit Medical Recent Developments/Updates

 Table 102. Terumo Company Information

 Table 103. Terumo Description and Business Overview

 Table 104. Terumo Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 105. Terumo Peripheral Vascular Intervention Products Product

 Table 106. Terumo Recent Developments/Updates

 Table 107. Teleflex Company Information

 Table 108. Teleflex Description and Business Overview

 Table 109. Teleflex Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 110. Teleflex Peripheral Vascular Intervention Products Product

 Table 111. Teleflex Recent Developments/Updates

 Table 112. Cook Medical Company Information

 Table 113. Cook Medical Description and Business Overview

 Table 114. Cook Medical Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 115. Cook Medical Peripheral Vascular Intervention Products Product

 Table 116. Cook Medical Recent Developments/Updates

 Table 117. Cordis Company Information

 Table 118. Cordis Description and Business Overview

 Table 119. Cordis Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 120. Cordis Peripheral Vascular Intervention Products Product

 Table 121. Cordis Recent Developments/Updates

 Table 122. Alvimedica Company Information

 Table 123. Alvimedica Description and Business Overview

 Table 124. Alvimedica Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 125. Alvimedica Peripheral Vascular Intervention Products Product

 Table 126. Alvimedica Recent Developments/Updates

 Table 127. Lepu Medical Company Information

 Table 128. Lepu Medical Description and Business Overview

 Table 129. Lepu Medical Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 130. Lepu Medical Peripheral Vascular Intervention Products Product

 Table 131. Lepu Medical Recent Developments/Updates

 Table 132. Guichuangtongqiao Company Information

 Table 133. Guichuangtongqiao Description and Business Overview

 Table 134. Guichuangtongqiao Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 135. Guichuangtongqiao Peripheral Vascular Intervention Products Product

 Table 136. Guichuangtongqiao Recent Developments/Updates

 Table 137. Xinmai Medical Company Information

 Table 138. Xinmai Medical Description and Business Overview

 Table 139. Xinmai Medical Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 140. Xinmai Medical Peripheral Vascular Intervention Products Product

 Table 141. Xinmai Medical Recent Developments/Updates

 Table 142. Xenrad Medical Company Information

 Table 143. Xenrad Medical Description and Business Overview

 Table 144. Xenrad Medical Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 145. Xenrad Medical Peripheral Vascular Intervention Products Product

 Table 146. Xenrad Medical Recent Developments/Updates

 Table 147. Xianjian Technology Company Information

 Table 148. Xianjian Technology Description and Business Overview

 Table 149. Xianjian Technology Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 150. Xianjian Technology Peripheral Vascular Intervention Products Product

 Table 151. Xianjian Technology Recent Developments/Updates

 Table 152. Weigao Shares Company Information

 Table 153. Weigao Shares Description and Business Overview

 Table 154. Weigao Shares Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 155. Weigao Shares Peripheral Vascular Intervention Products Product

 Table 156. Weigao Shares Recent Developments/Updates

 Table 157. Bomei Medical Company Information

 Table 158. Bomei Medical Description and Business Overview

 Table 159. Bomei Medical Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 160. Bomei Medical Peripheral Vascular Intervention Products Product

 Table 161. Bomei Medical Recent Developments/Updates

 Table 162. Dingke Medical Company Information

 Table 163. Dingke Medical Description and Business Overview

 Table 164. Dingke Medical Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 165. Dingke Medical Peripheral Vascular Intervention Products Product

 Table 166. Dingke Medical Recent Developments/Updates

 Table 167. Zhejiang Batai Medical Company Information

 Table 168. Zhejiang Batai Medical Description and Business Overview

 Table 169. Zhejiang Batai Medical Peripheral Vascular Intervention Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 170. Zhejiang Batai Medical Peripheral Vascular Intervention Products Product

 Table 171. Zhejiang Batai Medical Recent Developments/Updates

 Table 172. Key Raw Materials Lists

 Table 173. Raw Materials Key Suppliers Lists

 Table 174. Peripheral Vascular Intervention Products Distributors List

 Table 175. Peripheral Vascular Intervention Products Customers List

 Table 176. Peripheral Vascular Intervention Products Market Trends

 Table 177. Peripheral Vascular Intervention Products Market Drivers

 Table 178. Peripheral Vascular Intervention Products Market Challenges

 Table 179. Peripheral Vascular Intervention Products Market Restraints

 Table 180. Research Programs/Design for This Report

 Table 181. Key Data Information from Secondary Sources

 Table 182. Key Data Information from Primary Sources

 Table 183. Authors List of This Report

List of Figures

 Figure 1. Product Picture of Peripheral Vascular Intervention Products

 Figure 2. Global Peripheral Vascular Intervention Products Market Value by Type (US$ Million), 2021–2032

 Figure 3. Global Peripheral Vascular Intervention Products Market Share by Type: 2025 & 2032

 Figure 4. Stent Product Picture

 Figure 5. Catheter Product Picture

 Figure 6. Guidewire Product Picture

 Figure 7. Sheath Product Picture

 Figure 8. Vena Cava Filter Product Picture

 Figure 9. Other Product Picture

 Figure 10. Global Peripheral Vascular Intervention Products Market Value by Vascular Bed (US$ Million), 2021–2032

 Figure 11. Global Peripheral Vascular Intervention Products Market Share by Vascular Bed: 2025 vs 2032

 Figure 12. Lower Limb Artery Product Picture

 Figure 13. Carotid/Neck Product Picture

 Figure 14. Vein Product Picture

 Figure 15. Renal/Visceral Artery Product Picture

 Figure 16. Other Product Picture

 Figure 17. Global Peripheral Vascular Intervention Products Market Value by Drug Strategy (US$ Million), 2021–2032

 Figure 18. Global Peripheral Vascular Intervention Products Market Share by Drug Strategy: 2025 vs 2032

 Figure 19. Non-drug Product Picture

 Figure 20. Drug-coated Product Picture

 Figure 21. Drug-eluting Product Picture

 Figure 22. Other Product Picture

 Figure 23. Global Peripheral Vascular Intervention Products Market Value by Application (US$ Million), 2021–2032

 Figure 24. Global Peripheral Vascular Intervention Products Market Share by Application: 2025 & 2032

 Figure 25. Arterial Diseases

 Figure 26. Venous Diseases

 Figure 27. Global Peripheral Vascular Intervention Products Revenue, (US$ Million), 2021 vs 2025 vs 2032

 Figure 28. Global Peripheral Vascular Intervention Products Market Size (US$ Million), 2021–2032

 Figure 29. Global Peripheral Vascular Intervention Products Sales (K Units), 2021–2032

 Figure 30. Global Peripheral Vascular Intervention Products Average Price (US$/Unit), 2021–2032

 Figure 31. Peripheral Vascular Intervention Products Report Years Considered

 Figure 32. Peripheral Vascular Intervention Products Sales Share by Manufacturers in 2025

 Figure 33. Global Peripheral Vascular Intervention Products Revenue Share by Manufacturers in 2025

 Figure 34. Top 5 and Top 10 Global Peripheral Vascular Intervention Products Players: Market Share by Revenue in Peripheral Vascular Intervention Products in 2025

 Figure 35. Peripheral Vascular Intervention Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

 Figure 36. Global Peripheral Vascular Intervention Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Figure 37. North America Peripheral Vascular Intervention Products Sales Market Share by Country (2021–2032)

 Figure 38. North America Peripheral Vascular Intervention Products Revenue Market Share by Country (2021–2032)

 Figure 39. United States Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 40. Canada Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 41. Europe Peripheral Vascular Intervention Products Sales Market Share by Country (2021–2032)

 Figure 42. Europe Peripheral Vascular Intervention Products Revenue Market Share by Country (2021–2032)

 Figure 43. Germany Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 44. France Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 45. U.K. Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 46. Italy Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 47. Russia Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 48. Asia Pacific Peripheral Vascular Intervention Products Sales Market Share by Region (2021–2032)

 Figure 49. Asia Pacific Peripheral Vascular Intervention Products Revenue Market Share by Region (2021–2032)

 Figure 50. China Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 51. Japan Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 52. South Korea Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 53. India Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 54. Australia Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 55. China Taiwan Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 56. Southeast Asia Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 57. Latin America Peripheral Vascular Intervention Products Sales Market Share by Country (2021–2032)

 Figure 58. Latin America Peripheral Vascular Intervention Products Revenue Market Share by Country (2021–2032)

 Figure 59. Mexico Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 60. Brazil Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 61. Argentina Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 62. Colombia Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 63. Middle East and Africa Peripheral Vascular Intervention Products Sales Market Share by Country (2021–2032)

 Figure 64. Middle East and Africa Peripheral Vascular Intervention Products Revenue Market Share by Country (2021–2032)

 Figure 65. Turkey Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 66. Saudi Arabia Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 67. UAE Peripheral Vascular Intervention Products Revenue Growth Rate (US$ Million), 2021–2032

 Figure 68. Global Sales Market Share of Peripheral Vascular Intervention Products by Type (2021–2032)

 Figure 69. Global Revenue Market Share of Peripheral Vascular Intervention Products by Type (2021–2032)

 Figure 70. Global Peripheral Vascular Intervention Products Price (US$/Unit) by Type (2021–2032)

 Figure 71. Global Sales Market Share of Peripheral Vascular Intervention Products by Application (2021–2032)

 Figure 72. Global Revenue Market Share of Peripheral Vascular Intervention Products by Application (2021–2032)

 Figure 73. Global Peripheral Vascular Intervention Products Price (US$/Unit) by Application (2021–2032)

 Figure 74. Peripheral Vascular Intervention Products Value Chain

 Figure 75. Channels of Distribution (Direct Vs Distribution)

 Figure 76. Bottom-up and Top-down Approaches for This Report

 Figure 77. Data Triangulation

 Figure 78. Key Executives Interviewed